Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran
- Karami H. , et al.
2. Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study
- Karami H. , et al.
3. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies
- Mousavi S.F. , et al.
4. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
- Doğrugörün A. , et al.
5. An Overview of the Action Plans of the Islamic Republic of Iran toward Elimination of Viral Hepatitis B and C
- Bolbanabad A.M. , et al.
6. Economic Burden of Inflammatory Bowel Disease in Shiraz, Iran
- Rahmati L. , et al.
7. Prevalence of HBV, HCV, and HIV Infections among Patients Undergoing Hemodialysis in Fasa, Iran: A Six-Year Follow-up Study
- Shamsdin S.A. , et al.
8. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS)
- Mansour-Ghanaei F. , et al.
9. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme
- Ali S. , et al.
10. Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients
- Vyas B.H. , et al.
11. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study
- Mahmoudvand S. , et al.
12. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review
- Mattingly T.J. , et al.
14. Seroepidemiology of hepatitis C among drug users at a detoxification center in Southeast China
- Zhang D. , et al.
15. Impact of severity of chronic liver disease on health-related economics
- Qazi Arisar F.A. , et al.
16. Prevalence of hepatitis e virus in thalassemia patients with hepatitis c in Tehran, Iran
- Dalvand N. , et al.
17. Hepatitis C virus-related policy-making in Iran: A stakeholder and social network analysis
- Behzadifar M. , et al.
18. Evaluation of direct acting antivirals efficiency in Turkish patients with chronic hepatitis C under strict rules
- Sarıgul F. , et al.
19. The role of insurance providers in supporting treatment and management of hepatitis C patients
- Behzadifar M. , et al.
20. Evaluating the prevalence of HBV, HCV, and HIV in hemodialysis patients in north Cyprus
- Güvenir M. , et al.
21. Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: A population-based Azar Cohort study
- Pouri A.A. , et al.
23. Non-healthcare costs of hepatitis C: a systematic review
- Pascual-Argente N. , et al.
24. MDR1 gene C3435T polymorphism in chronic hepatitis C patients
- Parsa Nahad M. , et al.